Pharma groups fall foul of China data transfer rules

Financial Times

‘’[The law] runs the risk of handicapping international scientific research in the exaggerated interest of national security and industrial policy, ‘’said Lester Ross, head of the policy committee at the American Chamber of Commerce in China and a partner at law firm Wilmer Hale.